Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | KHK | P50053 | 1/20 | 0.48 |
| ▸ | TRPV4 | Q9HBA0 | 4/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 5/20 | 0.42 |
| ▸ | PGK1 | P00558 | 1/20 | 0.39 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 3/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.37 |
| ▸ | FASN | P49327 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7575800 | 0.88 | ALDH1A1 (0.50) | ALDH1A1KHKTRPV4CYP11B2PGK1 | |
| SCHEMBL10947192 | 0.88 | TRPV4 (0.56) | ALDH1A1KHKTRPV4CYP11B2PGK1 | |
| SCHEMBL30110369 | 0.88 | ALDH1A1 (0.50) | ALDH1A1KHKTRPV4CYP11B2PGK1 | |
| SCHEMBL7931517 | 0.88 | ALDH1A1 (0.46) | ALDH1A1KHKTRPV4CYP11B2PGK1 | |
| SCHEMBL1880028 | 0.83 | TRPV4 (0.56) | ALDH1A1KHKTRPV4CYP11B2VCAM1 | |
| SCHEMBL31504178 | 0.83 | TRPV4 (0.56) | ALDH1A1KHKTRPV4CYP11B2VCAM1 | |
| SCHEMBL2474467 | 0.82 | ALDH1A1 (0.46) | ALDH1A1KHKTRPV4CYP11B2PGK1 | |
| SCHEMBL2476965 | 0.82 | KHK (0.52) | ALDH1A1KHKTRPV4CYP11B2PGK1 | |
| SCHEMBL2479059 | 0.82 | ALDH1A1 (0.46) | ALDH1A1KHKTRPV4CYP11B2PGK1 | |
| SCHEMBL3338849 | 0.82 | ALDH1A1 (0.42) | ALDH1A1KHKTRPV4CYP11B2PGK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0431373-B1 | Processes for producing 5-fluorbenzoic acids and their intermediates | ASAHI GLASS CO LTD (JP) | 1996-04-10 | — | — | EP | claimed |
| EP-0497239-A1 | 2-Chloro-4,5-difluorobenzonitrile and process for preparation thereof | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-08-05 | — | — | EP | claimed |
| EP-0431373-A2 | Processes for producing 5-fluorbenzoic acids and their intermediates | ASAHI GLASS COMPANY LTD. (JP) | 1991-06-12 | — | — | EP | claimed |
| CN-1009920-B | Halogenated benzoic acid derivatives and their preparation | KYORIN SEIYAKU KK (JP) | 1990-10-10 | — | — | CN | claimed |
| CN-87100373-A | Halogenated benzoic acid derivative and preparation thereof | — | 1987-08-19 | — | — | CN | claimed |
| JP-6016613-A | — | — | None | — | — | JP | disclosed |
| US-20250100981-A1 | Cis-substituted 5-(hydroxymethyl)morpholine-2-carboxamides as agonists of SSTR4 | BOEHRINGER INGELHEIM INT (DE) | 2025-03-27 | — | — | US | disclosed |
| WO-2025027049-A1 | (2S,5R)-5-(HYDROXYMETHYL)MORPHOLINE-2-CARBOXAMIDES AS AGONISTS OF SSTR4 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2025-02-06 | — | — | WO | disclosed |
| US-11957049-B2 | Organic molecules, in particular for use in optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-04-09 | — | — | US | disclosed |
| CN-109563120-B | alpha-D-galactoside inhibitors of galectins | 格莱克特生物技术公司 | 2022-12-02 | — | — | CN | disclosed |
| US-10988502-B2 | Alpha-D-galactoside inhibitors of galectins | GALECTO BIOTECH AB (DK) | 2021-04-27 | — | — | US | disclosed |
| US-20190225638-A1 | ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS | GALECTO BIOTECH AB (DK) | 2019-07-25 | — | — | US | disclosed |
| EP-0497239-A1 | 2-Chloro-4,5-difluorobenzonitrile and process for preparation thereof | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-08-05 | — | — | EP | disclosed |
| EP-0433124-A1 | 2,4-Dichloro-5-fluorobenzonitrile and methods for its preparation, its use in the preparation of 2-chloro-4,5-difluorobenzoic acid and new method of preparation of this acid | ISOCHEM (FR) | 1991-06-19 | — | — | EP | disclosed |
| EP-0431373-A2 | Processes for producing 5-fluorbenzoic acids and their intermediates | ASAHI GLASS COMPANY LTD. (JP) | 1991-06-12 | — | — | EP | disclosed |
| CN-1009920-B | Halogenated benzoic acid derivatives and their preparation | KYORIN SEIYAKU KK (JP) | 1990-10-10 | — | — | CN | disclosed |
| CN-1008732-B | Benzoyl acetate derivative and preparation method thereof | KYORIN SEIYAKU KK (JP) | 1990-07-11 | — | — | CN | disclosed |
| CN-87100382-A | Benzoylacetic acid ester derivatives and preparation method thereof | — | 1987-09-02 | — | — | CN | disclosed |
| CN-87100373-A | Halogenated benzoic acid derivative and preparation thereof | — | 1987-08-19 | — | — | CN | disclosed |
| CN-87100387-A | Process for preparing quinolone carboxylic acid derivatives | — | 1987-08-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11957049-B2 | Organic molecules, in particular for use in optoelectronic devices | OR10J3, ORC3, ORAI3 | ALDH1A1 1636/4885KHK 3983/4885TRPV4 324/4885 |
| US-20190225638-A1 | ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS | LGALS1, LGALS2, LGALS3 | ALDH1A1 561/4885KHK 3388/4885TRPV4 4227/4885 |
| US-20250100981-A1 | Cis-substituted 5-(hydroxymethyl)morpholine-2-carboxamides as agonists of SSTR4 | SSTR4, SSTR5, SSTR2 | ALDH1A1 4226/4885KHK 2501/4885TRPV4 250/4885 |
| US-10988502-B2 | Alpha-D-galactoside inhibitors of galectins | LGALS1, LGALS2, LGALS3 | ALDH1A1 561/4885KHK 3388/4885TRPV4 4227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.